Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene)-1-imidazolylacetonitrile
2. Latoconazole
3. Latoconazole, (e)-isomer
4. Latoconazole, (z)-isomer
5. Nnd 318
6. Nnd-318
1. 101530-10-3
2. Latoconazole
3. Astat
4. Nnd-318
5. Tjn-318
6. Lanoconazole [inn]
7. 126509-69-1
8. (2e)-2-[4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile
9. Dsstox_gsid_46428
10. 153222-93-6
11. 4e7858311f
12. 1h-imidazole-1-acetonitrile, Alpha-(4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene)-, (alphae)-
13. 1h-imidazole-1-acetonitrile, Alpha-[4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene]-, (alphae)-
14. Brn 4819111
15. [4-(2-chloro-phenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-yl-acetonitrile
16. Unii-4e7858311f
17. Ncgc00164544-01
18. Astat (tn)
19. Lanoconazole [mi]
20. (4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene)-1-imidazolylacetonitrile
21. Lanoconazole [jan]
22. Lanoconazole (jp17/inn)
23. (+-)-(e)-(4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene)-1-imidazolylacetonitrile
24. (e)-alpha-(4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene)-1h-imidazole-1-acetonitrile
25. Lanoconazole [mart.]
26. Lanoconazole [who-dd]
27. Schembl342635
28. Chembl1555126
29. Chebi:31761
30. Amy32553
31. Bdbm50248305
32. 2-[4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-yl-acetonitrile
33. Akos015900193
34. Ac-5318
35. At35543
36. (+-)-alpha-((e)-4-(o-chlorophenyl)-1,3-dithiolan-2-ylidene)imidazole-1-acetonitrile
37. (2e)-2-[4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-yl-acetonitrile
38. 1h-imidazole-1-acetonitrile, Alpha-(4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene)-
39. 1h-imidazole-1-acetonitrile, Alpha-(4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene)-, (e)-(+-)-
40. As-12927
41. Lanoconazole 100 Microg/ml In Acetonitrile
42. D01092
43. Lanoconazole, Vetranal(tm), Analytical Standard
44. 530l103
45. Sr-01000945047
46. J-000422
47. Sr-01000945047-1
48. Q27259479
49. Alpha-[4-(2-chlorophenyl)-1,3-dithiolane-2-ylidene]-1h-imidazole-1-acetonitrile
50. (+/-)-.alpha.-((e)-4-(o-chlorophenyl)-1,3-dithiolan-2-ylidene)imidazole-1-acetonitrile
Molecular Weight | 319.8 g/mol |
---|---|
Molecular Formula | C14H10ClN3S2 |
XLogP3 | 3.3 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 319.0004674 g/mol |
Monoisotopic Mass | 319.0004674 g/mol |
Topological Polar Surface Area | 92.2 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 445 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
A Lanoconazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lanoconazole, including repackagers and relabelers. The FDA regulates Lanoconazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lanoconazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lanoconazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lanoconazole supplier is an individual or a company that provides Lanoconazole active pharmaceutical ingredient (API) or Lanoconazole finished formulations upon request. The Lanoconazole suppliers may include Lanoconazole API manufacturers, exporters, distributors and traders.
click here to find a list of Lanoconazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Lanoconazole Drug Master File in Japan (Lanoconazole JDMF) empowers Lanoconazole API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Lanoconazole JDMF during the approval evaluation for pharmaceutical products. At the time of Lanoconazole JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Lanoconazole suppliers with JDMF on PharmaCompass.
Lanoconazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lanoconazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lanoconazole GMP manufacturer or Lanoconazole GMP API supplier for your needs.
A Lanoconazole CoA (Certificate of Analysis) is a formal document that attests to Lanoconazole's compliance with Lanoconazole specifications and serves as a tool for batch-level quality control.
Lanoconazole CoA mostly includes findings from lab analyses of a specific batch. For each Lanoconazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lanoconazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Lanoconazole EP), Lanoconazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lanoconazole USP).
LOOKING FOR A SUPPLIER?